SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form D/A - Notice of Exempt Offering of Securities: [Amend]
SEC Accession No. 0001740279-18-000002
Filing Date
2018-09-20
Accepted
2018-09-20 16:05:26
Documents
1
Effectiveness Date
2018-09-20
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D/A  
1 primary_doc.xml D/A 6329
  Complete submission text file 0001740279-18-000002.txt   7373
Mailing Address 79 MADISON AVENUE, 2ND FLOOR NEW YORK NY 10016
Business Address 79 MADISON AVENUE, 2ND FLOOR NEW YORK NY 10016 (646) 820-8474
Incysus Therapeutics, Inc. (Filer) CIK: 0001740279 (see all company filings)

IRS No.: 825462585 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D/A | Act: 33 | File No.: 021-312981 | Film No.: 181079485